Pure Global

BIOPORT CROSSLINK 2.0% Intra-articular Injection - Taiwan Registration cbfaa078304cea82cd2db0a2cf2f2665

Access comprehensive regulatory information for BIOPORT CROSSLINK 2.0% Intra-articular Injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number cbfaa078304cea82cd2db0a2cf2f2665 and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
cbfaa078304cea82cd2db0a2cf2f2665
Registration Details
Taiwan FDA Registration: cbfaa078304cea82cd2db0a2cf2f2665
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BIOPORT CROSSLINK 2.0% Intra-articular Injection
TW: ็™พๆจ‚็Žป้—œ็ฏ€ๅ…งๆณจๅฐ„ๅŠ‘
Risk Class 3
MD

Registration Details

cbfaa078304cea82cd2db0a2cf2f2665

Ministry of Health Medical Device Manufacturing No. 007515

Company Information

Taiwan, Province of China

Product Details

Details are as detailed as approved Chinese instructions

N Orthopedics

N0003 Hyaluronic acid implants for the joint cavity

Produced in Taiwan, China

Dates and Status

Jul 26, 2022

Oct 13, 2026